| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-06 |